Use of central nervous system drugs in combination with selective serotonin reuptake inhibitor treatment: A Bayesian screening study for risk of suicidal behavior

Use of central nervous system drugs in combination with selective serotonin reuptake inhibitor treatment: A Bayesian screening study for risk of suicidal behavior

BackgroundUsing other central nervous system (CNS) medications in combination with selective serotonin reuptake inhibitor (SSRI) treatment is common. Despite this, there is limited evidence on the impact on suicidal behavior of combining specific medications. We aim to provide evidence on signals fo...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Tyra Lagerberg, Arvid Sjölander, Robert D. Gibbons, Patrick D. Quinn, Brian M. D’Onofrio, Clara Hellner, Paul Lichtenstein, Seena Fazel, Zheng Chang
التنسيق: مقال
اللغة:English
منشور في: Frontiers Media S.A. 2022-11-01
سلاسل:Frontiers in Psychiatry
الموضوعات:
screening study
selective serotonin reuptake inhibitor
suicidal behavior
central nervous system drugs
Bayesian
الوصول للمادة أونلاين:https://www.frontiersin.org/articles/10.3389/fpsyt.2022.1012650/full

الانترنت

https://www.frontiersin.org/articles/10.3389/fpsyt.2022.1012650/full

مواد مشابهة